Dr. Daniel Katz, MD
NPI: 1104910082
Total Payments
$88,357
2024 Payments
$1,178
Companies
49
Transactions
517
Medicare Patients
19,224
Medicare Billing
$1.6M
Payment Breakdown by Category
Research$44,350 (50.2%)
Other$29,080 (32.9%)
Food & Beverage$10,053 (11.4%)
Travel$4,220 (4.8%)
Education$654.77 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $44,350 | 22 | 50.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,080 | 12 | 32.9% |
| Food and Beverage | $10,053 | 452 | 11.4% |
| Travel and Lodging | $4,220 | 8 | 4.8% |
| Education | $654.77 | 23 | 0.7% |
Payments by Type
Research
$44,350
22 transactions
General
$44,007
495 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Coloplast Corp | $44,532 | 34 | $0 (2022) |
| Astellas Pharma US Inc | $28,663 | 57 | $0 (2024) |
| Allergan, Inc. | $3,322 | 29 | $0 (2021) |
| Boston Scientific Corporation | $3,039 | 5 | $0 (2023) |
| Medtronic, Inc. | $2,791 | 113 | $0 (2024) |
| Medtronic USA, Inc. | $1,540 | 102 | $0 (2020) |
| Valencia Technologies Corporation | $913.39 | 3 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $376.08 | 15 | $0 (2023) |
| PFIZER INC. | $287.76 | 25 | $0 (2024) |
| Caldera Medical, Inc | $263.96 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,178 | 49 | Medtronic, Inc. ($556.60) |
| 2023 | $2,134 | 44 | Valencia Technologies Corporation ($913.39) |
| 2022 | $1,531 | 55 | Medtronic, Inc. ($885.92) |
| 2021 | $2,043 | 49 | COLOPLAST CORP ($1,018) |
| 2020 | $4,916 | 48 | Astellas Pharma US Inc ($2,564) |
| 2019 | $8,286 | 102 | Astellas Pharma US Inc ($5,031) |
| 2018 | $21,725 | 89 | Coloplast Corp ($10,505) |
| 2017 | $46,545 | 81 | Coloplast Corp ($29,316) |
All Payment Transactions
517 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/19/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Diagnostic Imaging | ||||||
| 12/16/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $23.20 | General |
| 12/13/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $89.10 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/05/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $20.76 | General |
| Category: Prostate cancer | ||||||
| 11/21/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Biological | ||||||
| 09/24/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $26.16 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 09/19/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: HORMONE THERAPY | ||||||
| 09/06/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/04/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $35.27 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/20/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $25.41 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 08/08/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/07/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 06/28/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $52.98 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 06/14/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $54.44 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 06/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Biological | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESTORELL | Coloplast Corp | $29,285 | 9 |
| RESTORELLE | Coloplast Corp | $14,065 | 12 |
| Restorelle Transvaginal Mesh versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse | COLOPLAST CORP | $1,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 4,597 | 18,977 | $1.4M | $375,102 |
| 2022 | 54 | 4,532 | 21,137 | $1.5M | $406,296 |
| 2021 | 53 | 5,000 | 23,084 | $1.7M | $443,989 |
| 2020 | 57 | 5,095 | 19,854 | $1.8M | $400,262 |
Total Patients
19,224
Total Services
83,052
Medicare Billing
$1.6M
Procedure Codes
212
All Medicare Procedures & Services
212 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 522 | 888 | $299,799 | $92,942 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 466 | 610 | $144,970 | $44,022 | 30.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 46 | 8,400 | $126,000 | $41,459 | 32.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 107 | 115 | $118,910 | $23,767 | 20.0% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 44 | 638 | $55,972 | $21,940 | 39.2% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 46 | 58 | $66,226 | $19,353 | 29.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 145 | 153 | $45,594 | $14,494 | 31.8% |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | Facility | 2023 | 26 | 36 | $127,284 | $11,804 | 9.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $38,943 | $11,719 | 30.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 694 | 1,287 | $96,525 | $11,450 | 11.9% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 31 | 31 | $53,852 | $10,129 | 18.8% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 26 | 26 | $25,662 | $6,121 | 23.9% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 48 | 83 | $14,567 | $5,710 | 39.2% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 30 | 30 | $17,310 | $5,188 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 88 | 97 | $14,475 | $4,650 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 62 | $11,478 | $4,152 | 36.2% |
| 57282 | Repair of pelvic ligaments through vagina | Facility | 2023 | 11 | 11 | $20,603 | $4,036 | 19.6% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 301 | 491 | $9,820 | $3,884 | 39.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 797 | 1,608 | $9,648 | $3,520 | 36.5% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Office | 2023 | 47 | 68 | $10,132 | $3,045 | 30.1% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 30 | 56 | $15,736 | $2,911 | 18.5% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 31 | 31 | $15,903 | $2,899 | 18.2% |
| 51705 | Simple change of bladder tube | Office | 2023 | 11 | 29 | $8,183 | $2,422 | 29.6% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 156 | 257 | $5,654 | $2,179 | 38.5% |
| 64590 | Insertion of peripheral or gastric neurostimulator generator | Facility | 2023 | 22 | 22 | $16,368 | $2,140 | 13.1% |
About Dr. Daniel Katz, MD
Dr. Daniel Katz, MD is a Urogynecology and Reconstructive Pelvic Surgery healthcare provider based in Poughkeepsie, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104910082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Katz, MD has received a total of $88,357 in payments from pharmaceutical and medical device companies, with $1,178 received in 2024. These payments were reported across 517 transactions from 49 companies. The most common payment nature is "" ($44,350).
As a Medicare-enrolled provider, Katz has provided services to 19,224 Medicare beneficiaries, totaling 83,052 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 212 distinct procedure/service records.
Ad
Practice Information
- Specialty Urogynecology and Reconstructive Pelvic Surgery
- Other Specialties Urology
- Location Poughkeepsie, NY
- Active Since 10/03/2006
- Last Updated 01/29/2020
- Taxonomy Code 207VF0040X
- Entity Type Individual
- NPI Number 1104910082
Products in Payments
- RESTORELLE (Device) $43,350
- MYRBETRIQ (Drug) $14,798
- Myrbetriq (Drug) $13,291
- INTERSTIM (Device) $4,301
- BOTOX THERAPEUTIC - HH (Biological) $2,985
- UPHOLD LITE (Device) $2,949
- Restorelle (Device) $1,000
- eCoin Device Kit (Device) $913.39
- BOTOX (Biological) $321.01
- Osphena (Drug) $268.59
- Desara (Device) $263.96
- Xofigo (Drug) $220.36
- INTRAROSA (Drug) $182.53
- UroLift (Device) $178.10
- Nubeqa (Drug) $155.72
- GEMTESA (Drug) $121.14
- ERLEADA (Drug) $115.53
- XTANDI (Drug) $111.74
- BOTOX THERAPEUTIC (Biological) $111.36
- XIAFLEX (Biological) $101.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.